When analyzing stocks, Pragya takes a fundamental approach and focuses on measuring a company's intrinsic value. Her goal is to help retail investors create successful portfolios to achieve financial success.
Clinical-stage biopharmaceuticals company Day One Biopharmaceuticals (DAWN) is still in its early stages of development and has yet to generate revenue. However, recent insider buying activity in the stock signals optimism about the company's prospects and significant upside potential for its shares. So, let's take a closer look at the stock… Jul 1, 2022| 1:08pm
Rite Aid (RAD) shares soared last week after the company reported stronger-than-expected first-quarter revenue growth and issued an upbeat sales forecast. However, given the company’s increasing losses and projected interest rate hikes, is it worth buying the stock now? Let’s find out... Jul 1, 2022| 8:55am
While Booking Holdings’ (BKNG) shares are down nearly 25% year-to-date, it is currently trading at a relatively premium valuation. So, let’s evaluate if it is worth adding the stock to your portfolio, given the current macroeconomic uncertainties that could threaten the travel industry's growth. Read on... Jun 30, 2022| 9:02am
NXP Semiconductors (NXPI) saw its shares get crushed despite reporting strong top-line and bottom-line growth in the last reported quarter. While several analysts recently lowered their price target on the stock, given increased chip demands across industries, can the stock maintain its market standing? Let’s find out... Jun 30, 2022| 8:30am
With inflation reaching a fresh high, the likelihood of the Fed going more proactive in tightening monetary policy may make tech stocks highly volatile in the coming weeks. However, as the increased reliance on technology solutions and policy assistance should continue to promote the growth of the IT industry, Wall Street analysts project fundamentally-sound technology services stocks Information Services Group (III) and Issuer Direct (ISDR) to soar in the coming months. Let’s evaluate these names... Jun 29, 2022| 9:24am
Despite witnessing double-digit revenue growth in the last reported quarter Natera Inc. (NTRA) stock has plunged nearly 60% year-to-date. So, let’s evaluate if it is worth buying the stock now. Read on... Jun 29, 2022| 8:55am
Shares of Utz Brands (UTZ) have dipped significantly in price as inflation continues to weigh on its growth. While the company witnessed stable revenue growth in the last reported quarter, its negative profit margins and relatively high valuation are concerning. Read on… Jun 28, 2022| 12:56pm
Given the uncertainty surrounding the market's momentum in the coming weeks, and as investors become more concerned about the Fed's forthcoming interest rate hikes, we believe it may be prudent to invest in penny stock VEON Ltd. (VEON) and GEE Group (JOB), which have solid upside potential. These stocks are rated Strong Buy in our proprietary rating system. Read on to learn more… Jun 28, 2022| 12:46pm
Rio Tinto (RIO) continues to invest in sustainable and growth projects to ensure stable shareholder returns. The company has a steady dividend growth history and a current dividend yield of 13%. So, is it worth buying the stock now? Let’s find out... Jun 27, 2022| 3:09pm
With increasing federal and private-sector investments and heightened healthcare spending, the healthcare sector is poised to grow. However, given the rising competition and lack of workforce, major facility-based care service providers Brookdale Senior Living (BKD) and Signify Health (SGFY) are experiencing a slowdown. So, these stocks are best avoided now. Keep reading… Jun 27, 2022| 9:14am